Rheinmetall Faces a Capacity Question in Artillery as Belgium Firms Up Skyranger Order

Rheinmetall's long-term investment case is increasingly being fought over shells rather than systems. Bank of America withdrew its buy recommendation on the German defence group on Thursday, warning that Europe's artillery ammunition production capacity could outstrip consumption from 2028 onward — a shift that would undercut both pricing and growth in what had been a core pillar of the bull thesis.

The bank sets a potential annual capacity of roughly 3.4 million rounds against consumption of 2.2 million. On that arithmetic, the build-out of European production lines only translates into additional business for Rheinmetall if procurement keeps pace with the larger supply pool. BofA is no longer convinced it will, and cut the stock to Neutral from Buy.

The downgrade carries a hard number. For 155mm artillery ammunition, the analysts now model mid-term revenue of around EUR 3 billion, down from roughly EUR 6 billion previously — halving one of the main building blocks of their earlier growth expectations. Skepticism extends beyond munitions: BofA also anticipates a slower trajectory in the vehicle business, leaving investors to watch both incoming orders and the execution of projects already booked.

Forecasts Trimmed Across the Board

For 2030, the bank now pencils in group revenue of EUR 31–32 billion, against around EUR 35 billion before. It expects a long-term margin of 18–19%, below the company's own target of more than 20%.

The more cautious stance follows Wednesday evening's guidance cut. Delays in Boxer projects and artillery ammunition are weighing on the expected trajectory, and according to Morningstar those delays also push back cash receipts — making the timing and reliability of growth, not just its scale, a growing part of the valuation debate.

Should investors sell immediately? Or is it worth buying Rheinmetall?

What still speaks for Rheinmetall is the prospect of substantial expansion, provided orders convert into revenue and earnings as planned. What argues against a swift return to earlier expectations, in BofA's view, is fading artillery momentum and possible price risk. The decisive question is how much earning power the additional volume actually generates.

Belgium Order Provides a Concrete Counterweight

Air defence offers a firmer counterpoint. Belgium is ordering 20 Skyranger-30 systems including logistics, a contract Rheinmetall values in the mid three-digit million-euro range, with deliveries due to begin at the end of 2028. The systems will be mounted on hooklift platforms in a stationary role to protect Belgian territory and critical infrastructure, integrated into the Blue Dome air defence architecture. Belgian technology companies are to be brought into the value chain, and the procurement is being coordinated closely with the Netherlands.

The contract gives the air defence business a concrete delivery outlook, though its contribution depends on the planned production ramp and on how the integration is executed. For investors, two developments now sit side by side: a confirmed Skyranger order and more cautious expectations for the long-term artillery business.

CEO Backs Words With Capital

Against that backdrop, chief executive Armin Papperger bought 585 shares on Thursday at an average price of EUR 858.9477, a total of EUR 502,484.40, according to the notification of management transactions. The purchase lands in a phase in which repeated guidance corrections have weighed on expectations for the company, and it ties the CEO's position to an additional financial commitment.

The context is the already-published second cut to full-year revenue guidance. Rheinmetall expects around EUR 13.2 billion in revenue for 2026, with delays in the Boxer/Arminius programme and in artillery ammunition testing hampering execution. The operating scorecard nonetheless shows robust growth: third-quarter 2026 revenue reached EUR 3.15 billion, with operating profit of EUR 553 million. The tension for investors lies in the gap between that vigorous growth and the repeated revisions to expectations.

JPMorgan analyst David Perry points to the fifth revenue or profit warning within eleven months. His firm cut its price target to EUR 1,150 from EUR 1,350 and maintained a neutral rating. Perry considers the strategy fundamentally sound but sees earlier targets as possibly too ambitious — an assessment that shifts the focus onto whether the planning is durable, since a convincing strategy needs goals that can be met operationally. Ahead of the capital markets day on 27 November 2026, JPMorgan placed Rheinmetall on a watch list for possible negative catalysts, where a revised 2030 plan could be presented.

That 27 November event is the next fixed marker. The viability of the growth targets, the expected margins and the execution of the order backlog will all be in focus. Additional orders strengthen Rheinmetall's prospects — as long as they turn reliably into profitable deliveries and cash receipts. Papperger's share purchase and the analysts' caution frame the same challenge from two directions: the CEO's personal stake argues for confidence, while the burden of proof remains tied to on-time execution.

Ad

Rheinmetall Stock: New Analysis - 9 November

Fresh Rheinmetall information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Rheinmetall analysis...